Olivia Spleiss

<i>RAS</i> Mutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors

Fei Su, Amaya Virós, Carla Milagre et al. · New England Journal of Medicine · 2012 · 1K citations · Full text

Pharmacodynamic Effects and Mechanisms of Resistance to Vemurafenib in Patients With Metastatic Melanoma

Kerstin Trunzer, Anna C. Pavlick, Lynn M. Schuchter et al. · Journal of Clinical Oncology · 2013 · 363 citations · Full text

Medicine, Receptor Tyrosine Kinase, -Mutant Melanoma +14

Analysis of Dermatologic Events in Vemurafenib-Treated Patients With Melanoma

Mario E. Lacouture, Madeleine Duvic, Axel Hauschild et al. · The Oncologist · 2013 · 213 citations · Full text

Circulating tumor <scp>DNA</scp> and circulating tumor cells in metastatic triple negative breast cancer patients

Jordan Madic, Anna Kiialainen, François‐Clément Bidard et al. · International Journal of Cancer · 2014 · 147 citations

Mechanisms of prostaglandin E2‐induced interleukin‐6 release in astrocytes: possible involvement of EP4‐like receptors, p38 mitogen‐activated protein kinase and protein kinase C

Bernd L. Fiebich, Sandra Schleicher, Olivia Spleiss et al. · Journal of Neurochemistry · 2001 · 123 citations

Immunology, Cell Death, P38 Mapk +23